Stay updated on Anti-viral Therapy in Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Anti-viral Therapy in Alzheimer's Disease Clinical Trial page.

Latest updates to the Anti-viral Therapy in Alzheimer's Disease Clinical Trial page
- Check5 days agoChange DetectedA notice about NIH’s terminology transition appears above the page, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check33 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the expected study details and preventing access to the record.SummaryDifference19%

- Check40 days agoChange DetectedThe page revision badge was updated from v3.6.6 to v3.7.0. This signals a backend or UI update behind the scenes rather than changes to the study details.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing the previous v3.6.5 revision. This indicates a minor update to the page metadata rather than changes to the study content or eligibility.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision tag 'Revision: v3.6.5' was added, replacing the previous 'Revision: v3.6.4'. This indicates a minor update to the page's documentation version.SummaryDifference0.1%

Stay in the know with updates to Anti-viral Therapy in Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-viral Therapy in Alzheimer's Disease Clinical Trial page.